Home › Foundation Medicine Q4 Revenues Grow 11 Percent

Foundation Medicine Q4 Revenues Grow 11 Percent

Feb 22, 2017

This article has been updated with information and comments from Foundation Medicine's earning call.

NEW YORK (GenomeWeb) – Foundation Medicine reported after the close of the market on Wednesday that its fourth quarter revenues climbed 11 percent, driven by strong growth from its biopharmaceutical business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

What's Popular?

In Molecular Diagnostics

  1. Dutch Researchers Develop ThromboSeq Test to Detect Lung Cancer

  2. Innovate UK Awards Atlas Genetics £2M Grant for Rapid Diagnostic Platform

  3. FDA Clears iCubate System, Bloodstream Infection Assay

  4. Reimbursement Uncertainty, Nanosphere Success Give Luminex Pause in Commercial Plan for Next Instrument

    Premium

  5. Curetis Posts 9 Percent Drop in H1 Revenues

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.